Complement Factor H Targeting Antibody GT103 in Refractory Non-Small Cell Lung Cancer: a Phase 1b Dose Escalation Trial
NATURE COMMUNICATIONS(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined